Company Filing History:
1 out of 243 
1 out of 832,718 Years Active: 1989-1997
Title: Jan Thurin: Innovator in Immunology
Introduction
Jan Thurin is a notable inventor based in Philadelphia, PA, who has made significant contributions to the field of immunology. With a total of two patents to his name, Thurin's work focuses on developing innovative solutions for medical challenges, particularly in cancer treatment.
Latest Patents
Thurin's latest patents include a matrix with immunomodulating activity and monoclonal antibodies against melanoma-associated antigens. The latter invention is particularly noteworthy as it involves monoclonal antibodies and hybridomas that produce them, which are reactive with ganglioside antigens GD2 and GD3 while being essentially non-reactive with other ganglioside antigens. This invention also encompasses methods for utilizing these antibodies in therapeutic applications.
Career Highlights
Throughout his career, Jan Thurin has worked at the Wistar Institute, where he has contributed to groundbreaking research in immunology. His work has been instrumental in advancing the understanding of cancer-related antigens and their potential for therapeutic use.
Collaborations
Thurin has collaborated with prominent figures in the field, including Hilary Koprowski and Meenhard Herlyn. These collaborations have further enriched his research and expanded the impact of his inventions.
Conclusion
Jan Thurin's innovative work in immunology, particularly through his patents, showcases his commitment to advancing medical science. His contributions are paving the way for new therapeutic approaches in cancer treatment.